7. Tokuda Y, Matsushima D, Stein GH, et al. Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions:a meta-analysis. Chest, 2006, 129:783-790.
[2]
8. Nie W, Liu Y, Ye J, et al. Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion:a meta-analysis of randomized control trials. Clin Respir J, 2014, 8:281-291.
[3]
9. St Peter SD, Tsao K, Spilde TL, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children:a prospective, randomized trial. J Pediatr Surg, 2009, 44:106-111.
[4]
10. Sonnappa S, Cohen G, Owens CM, et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med, 2006, 174:221-227.
[5]
1. Finley C, Clifton J, Fitzgerald JM, et al. Empyema:an increasing concern in Canada. Can Respir J, 2008, 15:85-89.
[6]
2. Farjah F, Symons RG, Krishnadasan B, et al. Management of pleural space infections:a population-based analysis. J Thorac Cardiovasc Surg, 2007, 133:3463-3451.
[7]
3. Ahmed AE, Yacoub TE. Empyema thoracis. Clin Med Insights Circ Respir Pulm Med, 2010, 4:1-8.
[8]
4. Maskell NA, Davies CW, Nunn AJ, et al; First Multicenter Intrapleural Sepsis Trial (MIST1) Group. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med, 2005, 352:865-874.
[9]
5. Davies HE, Davies RJ, Davies CW; BTS Pleural Disease Guideline Group. Management of pleural infection in adults:British Thoracic Society Pleural Disease Guideline 2010. Thorax, 2010, 65(Suppl 2):ii41-53.
[10]
6. Maskell NA, Batt S, Hedley EL, et al. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med, 2006, 174:817-823.
[11]
11. McCauley L, Dean N. Pneumonia and empyema:causal, casual or unknown. J Thorac Dis, 2015, 7:992-998.
